|
Fully sequential Bayesian clinical trial design for in-hospital treatment of COVID-19
|
|
23
|
2140
|
May 23, 2020
|
|
First RCT of Lopinavir–Ritonavir on SARS-CoV2
|
|
38
|
3936
|
May 19, 2020
|
|
Open-label RCT of triple combination (LPV/r, Ribavirin, Interferon) on SARS-CoV2
|
|
2
|
352
|
May 15, 2020
|
|
SARS-CoV2 Testing: How Does PPV Factor into Discussion of Test Performance?
|
|
5
|
316
|
May 12, 2020
|
|
COVID-19 Research Methods Resources
|
|
11
|
2438
|
May 4, 2020
|
|
Illness Severity among Non-COVID patients
|
|
12
|
1152
|
April 19, 2020
|
|
French target trial using obs data of HCQ vs not in SARS-CoV-2 infection
|
|
1
|
208
|
April 15, 2020
|
|
Visualization for Benefit of COVID-19 Testing for Decreasing Provider Risk During Intubation
|
|
2
|
283
|
April 2, 2020
|
|
Power calculations for cluster-RCT in hospital infection control (PPE for Covid19)
|
|
7
|
418
|
April 1, 2020
|
|
COVID-19 Death Prediction Modeling Strategy Discussion
|
|
1
|
338
|
March 29, 2020
|
|
"Impressive" or "anecdotal"? Hydroxychloroquine + Azithromycin vs COVID-19 preprint
|
|
5
|
777
|
March 22, 2020
|
|
Imperial College Paper on Interventions to Reduce COVID-19 Population Level Impact
|
|
1
|
641
|
March 19, 2020
|
